Alopecia, a new US drug treats 40% of patients: the FDA asked for ok
A new alopecia drug shows impressive results. Here are the updates from phase three of the trial
Read MoreA new alopecia drug shows impressive results. Here are the updates from phase three of the trial
Read MoreThe US authority rewards the multi-year efforts of the creators of the best glucose control system in patients with diabetes: an artificial pancreas.
Read MoreThe “miracle” electronic glasses that quickly cure myopia are officially on sale in Japan
Read MoreThe reprogramming of patients' pancreatic cells has brought important first results, allowing patients with diabetes to produce insulin again.
Read MoreElevian appears to have the edge in finding ways to increase lifespan, in this case using a protein called GDF11. But there are challenges to be faced.
Read MoreAn out-of-scale TV in everything: foldable, gigantic, very expensive and with artistic ambitions: the metal sculpture is transformed into a giant screen.
Read MoreAn innovative (but intelligent) underground and autonomous transport system will allow Switzerland to cut traffic and pollution.
Read MoreA display that is always "visible", because it is positioned directly on the eye: augmented reality contact lenses make great strides towards complete realization.
Read MoreMYRO International company produces innovative robots, capable of painting an entire housing complex in less than four hours.
Read MoreFuturoprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.
To contact the FuturoProssimo editorial team, write to [email protected]
This work is distributed under license Creative Commons Attribution 4.0 International.
© 2021 Futuroprossimo